Sumit K. Shah

High Impact

Research Assistant

UAMS

Last publication 2025 Last refreshed 2026-05-02

grad_student

20 h-index 63 pubs 1,216 cited

Research Areas

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Sumit K. Shah's research focuses on understanding factors influencing health behaviors and outcomes, particularly in the context of infectious diseases and cancer screening. His work has investigated the sociodemographic determinants of COVID-19 vaccine hesitancy, exploring the impact of fear of infection and self-efficacy among diverse adult populations. He has also examined experiences of discrimination and its correlation with vaccine hesitancy among Black adults and US adults more broadly. Furthermore, Shah has studied parental intentions regarding COVID-19 vaccination for children and explored the personal beliefs and feelings associated with vaccine acceptance.

Beyond infectious diseases, his research extends to cancer screening disparities. He has assessed colorectal cancer screening utilization among men and women in the U.S. and investigated factors associated with breast cancer screening service use among women, applying established health service use models. Shah leads a research group and has a notable publication record with 63 total publications and 1,194 citations, achieving an h-index of 20. He has collaborated extensively with researchers at the University of Arkansas for Medical Sciences, including Pearl A. McElfish, James Selig, Don E. Willis, and Sharon Reece.

Metrics

h-index: 20
Publications: 63
Citations: 1,216

Selected Publications

Correction: Associations Between General Vaccine Hesitancy and Healthcare Access Among Arkansans (2025)

DOI OpenAlex
Corrigendum to “COVID-19 vaccine hesitancy and racial discrimination among US adults” [Pre. Med. Rep. 31 (2022) 102074] (2025)

DOI OpenAlex
Acute Myeloid Leukemia with Hemophagocytosis: Diagnostic Cues and Potential Pitfalls. (2025)

OpenAlex
A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025)

2 citations DOI OpenAlex
Evusheld, a SARS-CoV-2 spike protein–directed attachment inhibitor, appears in serum protein electrophoresis and immunofixation: a case study (2023)

1 citation DOI OpenAlex
A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023)

2 citations DOI OpenAlex
Factors associated with breast cancer screening services use among women in the United States: An application of the Andersen's Behavioral Model of Health Services Use (2023)

19 citations DOI OpenAlex
Comparing community-driven COVID-19 vaccine distribution methods: Faith-based organizations vs. outpatient clinics (2022)

6 citations DOI OpenAlex
COVID-19 vaccine hesitancy and racial discrimination among US adults (2022)

40 citations DOI OpenAlex
Associations Between General Vaccine Hesitancy and Healthcare Access Among Arkansans (2022)

15 citations DOI OpenAlex
Assessment of Colorectal Cancer Screening Disparities in U.S. Men and Women Using a Demographically Representative Sample (2022)

22 citations DOI OpenAlex
Associations between 5-year influenza vaccination and sociodemographic factors and healthcare access among Arkansans (2022)

8 citations DOI OpenAlex
Parent/guardian intentions to vaccinate children against COVID-19 in the United States (2022)

27 citations DOI OpenAlex
COVID-19 Vaccine Hesitancy and Experiences of Discrimination Among Black Adults (2022)

63 citations DOI OpenAlex
Parents’ and Guardians’ Intentions to Vaccinate Children against COVID-19 (2022)

21 citations DOI OpenAlex